EDGAR Filing Documents for 0001193125-18-135055

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-18-135055

Filing Date

2018-04-26

Accepted

2018-04-26 16:50:55

Documents

Effectiveness Date

2018-04-26

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d566466ddefa14a.htm	DEFA14A	36399
2	GRAPHIC	g56646612.jpg	GRAPHIC	2585
3	GRAPHIC	g566466dsp4snap4.jpg	GRAPHIC	1403
4	GRAPHIC	g566466dsp7snap1.jpg	GRAPHIC	1408
5	GRAPHIC	g566466g33p26.jpg	GRAPHIC	3423
6	GRAPHIC	g566466g55q60.jpg	GRAPHIC	3438
7	GRAPHIC	g566466g97m83.jpg	GRAPHIC	16028
	Complete submission text file	0001193125-18-135055.txt		77340

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36783 | Film No.: 18779334
SIC: 2834 Pharmaceutical Preparations